Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ARVN | Common Stock | Options Exercise | $948K | +20K | +726.22% | $47.38 | 22.8K | Jun 30, 2021 | Direct | F1 |
transaction | ARVN | Common Stock | Sale | -$1.53M | -20K | -87.9% | $76.69 | 2.75K | Jun 30, 2021 | Direct | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ARVN | Stock Option (right to buy) | Options Exercise | $0 | -20K | -26.67% | $0.00 | 55K | Jun 30, 2021 | Common Stock | 20K | $47.38 | Direct | F1, F4 |
Id | Content |
---|---|
F1 | The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020. |
F2 | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.20 to $77.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range set forth in this footnote (3). |
F4 | This option award was granted on February 27, 2020, 1/4 of the shares underlying the award shall vest on February 27, 2021, with the remainder of the shares vesting in equal monthly installments following February 27, 2021 through February 27, 2024. |